Rating History for Eliem Therapeutics Inc. (ELYM) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for ELYM
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/25/2022 Yatin Suneja Downgrade Neutral
(Buy)		 N/A
(N/A)		 6.51
(5.11)		 -21.51% Details